Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Echo Therapeutics Inc Announces Closing Of Public Offering Of Common Stock

Wednesday, 6 Feb 2013 12:00pm EST 

Echo Therapeutics Inc announced the closing of a previously announced underwritten public offering of 13,633,333 shares of its common stock and the full exercise of the over-allotment option to purchase 2,045,000 additional shares, offered at a price to the public of $0.75 per share. The gross proceeds to Echo from this offering are approximately $11.76 million, before deducting the underwriting discount and other estimated offering expenses payable by Echo. Aegis Capital Corp. acted as the sole book-running manager for the offering. 

Company Quote

-0.06 -3.85%
23 Dec 2014